Literature DB >> 31553637

Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD.

Pierre-Marie Andrault1,2, Andrea C Schamberger3, Thibault Chazeirat1,2, Damien Sizaret1,4, Justine Renault1, Claudia A Staab-Weijnitz3, Elisabeth Hennen3, Agnès Petit-Courty1,2, Mylène Wartenberg1,2, Ahlame Saidi1,2, Thomas Baranek1,2, Serge Guyetant1,4, Yves Courty1,2, Oliver Eickelberg3, Gilles Lalmanach1,2, Fabien Lecaille1,2.   

Abstract

Cigarette smoking has marked effects on lung tissue, including induction of oxidative stress, inflammatory cell recruitment, and a protease/antiprotease imbalance. These effects contribute to tissue remodeling and destruction resulting in loss of lung function in chronic obstructive pulmonary disease (COPD) patients. Cathepsin S (CatS) is a cysteine protease that is involved in the remodeling/degradation of connective tissue and basement membrane. Aberrant expression or activity of CatS has been implicated in a variety of diseases, including arthritis, cancer, cardiovascular, and lung diseases. However, little is known about the effect of cigarette smoking on both CatS expression and activity, as well as its role in smoking-related lung diseases. Here, we evaluated the expression and activity of human CatS in lung tissues from never-smokers and smokers with or without COPD. Despite the presence of an oxidizing environment, CatS expression and activity were significantly higher in current smokers (both non-COPD and COPD) compared with never-smokers, and correlated positively with smoking history. Moreover, we found that the exposure of primary human bronchial epithelial cells to cigarette smoke extract triggered the activation of P2X7 receptors, which in turns drives CatS upregulation. The present data suggest that excessive CatS expression and activity contribute, beside other proteases, to the deleterious effects of cigarette smoke on pulmonary homeostasis.

Entities:  

Keywords:  COPD; cigarette smoke; cysteine protease; oxidation; smokers

Year:  2019        PMID: 31553637     DOI: 10.1152/ajplung.00061.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

Review 1.  Extracellular Vesicles as Central Mediators of COPD Pathophysiology.

Authors:  Derek W Russell; Kristopher R Genschmer; J Edwin Blalock
Journal:  Annu Rev Physiol       Date:  2021-11-01       Impact factor: 19.318

2.  Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice.

Authors:  Ryan Brown; Donna M Small; Declan F Doherty; Leslie Holsinger; Robert Booth; Richard Williams; Rebecca J Ingram; J Stuart Elborn; Marcus A Mall; Clifford C Taggart; Sinéad Weldon
Journal:  Mediators Inflamm       Date:  2021-03-19       Impact factor: 4.711

Review 3.  Aberrant Post-Transcriptional Regulation of Protein Expression in the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Noof Aloufi; Aeshah Alluli; David H Eidelman; Carolyn J Baglole
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

Review 4.  Cellular and Molecular Signatures of Oxidative Stress in Bronchial Epithelial Cell Models Injured by Cigarette Smoke Extract.

Authors:  Chiara Cipollina; Andreina Bruno; Salvatore Fasola; Marta Cristaldi; Bernardo Patella; Rosalinda Inguanta; Antonio Vilasi; Giuseppe Aiello; Stefania La Grutta; Claudia Torino; Elisabetta Pace
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

Review 5.  Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.

Authors:  Ryan Brown; Sridesh Nath; Alnardo Lora; Ghassan Samaha; Ziyad Elgamal; Ryan Kaiser; Clifford Taggart; Sinéad Weldon; Patrick Geraghty
Journal:  Respir Res       Date:  2020-05-12

Review 6.  Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease.

Authors:  Sebastian T Lugg; Aaron Scott; Dhruv Parekh; Babu Naidu; David R Thickett
Journal:  Thorax       Date:  2021-05-13       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.